Public filings / CAI on Yahoo Finance (opens in a new tab)
CAI: insider buying, 13F holders, analyst moves
Caris Life Sciences Inc
A summary of public filings about Caris Life Sciences Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
4 of our 100 managers hold CAI
Combined reported value $332.2M.
Holders among our 100 managers: 0 in Q3 2023, 4 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Coatue Management | $175.0M | 0.36% | Unchanged |
| PointState Capital | $121.7M | 2.14% | Trimmed |
| Duquesne Family Office | $33.8M | 0.78% | Unchanged |
| Tudor Investment | $1.8M | 0.01% | Unchanged |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.